pfizer shares sink on weak 2024 revenue, profit forecasts
Published 9 months ago • 8.8K plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:30
pfizer beats eps estimates; stock falls on lower yearly guidance
-
1:40
pfizer q2 earnings: $0.78 per share vs $0.66 eps expected
-
1:25
pfizer reports first-quarter earnings, records $13.2 billion in covid vaccine revenue
-
2:17
jim cramer on pfizer's q4 earnings and full-year guidance
-
0:21
final trades: pfizer, alphabet and amazon
-
1:04
pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-covid sales
-
6:34
there's valuation opportunities here for china, says neuberger berman's conrad saldanha
-
3:44
pfizer ceo: cancer drugs will be our next big contribution to the world
-
3:14
china stocks have best week since 2008 following beijing stimulus plans
-
1:21
pfizer forecasts $15 billion in revenue from covid-19 vaccine in 2021
-
1:51
pfizer beats on top and bottom lines
-
1:43
pfizer posts earnings miss, revenue beat
-
1:26
pfizer posts better-than-expected q3 earnings
-
1:25
pfizer beats earnings estimates as declining covid business performs better than expected
-
3:46
josh brown buys more pfizer
-
1:38
pfizer raises full-year sales guidance after earnings beat estimates
-
2:11
pfizer beats earnings expectations, raising full-year guidance
-
1:10
pfizer posts light eps beat but misses on revenue in q3
-
3:52
bofa's geoff meacham on pfizer earnings: the story is still about covid contraction
-
5:01
pfizer executed earnings well: stephanie link
-
5:21
melius' ben reitzes on why nvidia remains his top chip stock
-
2:34
pfizer, merck both post earnings beats